Natrox

Waterbeach, United Kingdom Founded: 2003 • Age: 23 yrs Minicorn
Oxygen-based wound therapy devices are developed for healing non-healing wounds.

About Natrox

Natrox is a company based in Waterbeach (United Kingdom) founded in 2003. Natrox has raised $68.39 million across 22 funding rounds from investors including Amadeus Capital Partners, Meltwind Advisory and Puhua Capital. Natrox operates in a competitive market with competitors including EO2Concepts, Vaporox, Advanced Oxygen Therapy, InotecAMD and Numobag, among others.

  • Headquarter Waterbeach, United Kingdom
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website natroxwoundcare.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Inotec Amd Limited
  • Date of Incorporation 23 Dec, 2003
  • Jurisdiction CAMBRIDGE, ENGLAND
Operational Areas
Key Metrics
  • Total Equity Funding
    $68.39M (USD)

    in 22 rounds

  • Latest Funding Round
    $33M (USD), Series C

    Dec 2024

  • Investors

Apps and channels of Natrox

its YouTube channel NATROX has 712 subscribers and 30 videos.

NATROX
YouTube 712 subscribers 30 videos Howto & Style
Open channel

Videos from Natrox

The most watched videos on Natrox's YouTube channel, NATROX (712 subscribers). Click a video to play it here.

From Hole to Healing: Gloria's NATROX® O₂ Journey
11.3K views
General Tips on How to Apply NATROX® O₂
5.2K views
NATROX® O₂ Tips & Tricks for Patients
3K views
Healing Steps: Ricardo's Journey with NATROX® O₂
2.3K views

More on NATROX.

Funding Insights of Natrox

Natrox has successfully raised a total of $68.39M across 22 strategic funding rounds. The most recent funding activity was a Series C round of $33 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $68.39M
  • Total Rounds 22
  • Last Round Series C — $33M
  • First Round $107,445

    (Apr 2005)

  • Investors Count 6

Latest 10 of 22 funding rounds of Natrox with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2024$33MSeries C–Amadeus Capital
Feb 2021$12.22MSeries C–WealthClub
–
Nov 2019$9.1MSeries A$31.98MPraetura Ventures
Mar 2019$3.45MSeed$9.48M–
–
Feb 2017$1.87MSeed$•••••–
–
Apr 2016$2.21MSeed$•••••–
–
Nov 2015$414,017Seed$•••••–
–
Oct 2015$1.14MSeed$•••••–
–
Sep 2014$995,007Seed$•••••–
–
Mar 2014$311,951Seed$•••••–
–
Valuation history
DateValuationStage
Nov 2019$31.98M••••••••
Mar 2019$9.48M••••••••
Feb 2017$•••••••••••••
Apr 2016$•••••••••••••
Nov 2015$•••••••••••••
Oct 2015$•••••••••••••
Sep 2014$•••••••••••••
Mar 2014$•••••••••••••
Premium access

Full valuation and stage history of Natrox

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $31.98M (Nov 2019). 6 investors in total: 6 institutional.

Investors in Natrox

Natrox has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Amadeus Capital Partners, Meltwind Advisory and Puhua Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Early-stage deep technology investments are made by Amadeus Capital.
–amadeuscapital.comLondon, United Kingdom
Health and technology startups are invested in by Puhua Capital.
–puhuacapital.comHangzhou, China
Venture capital funding is provided by Praetura Ventures.
–praeturaventures.comManchester, United Kingdom
-
–boundarycapital.com-
Offers medical advisory services for the life science and biopharma industries.
2014meltwind.co.ukCambridge, United States
Offers tax-efficient investments and portfolios for high net worth individuals.
2016wealthclub.co.ukBristol, United Kingdom
Premium access

Investor details for Natrox

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Natrox

19 people are tracked at Natrox (8 in leadership, 5 in board & advisors, 6 in team).

NameRoleGroup
John Adam
Chief Operating OfficerLeadership
Gordie Nye
CEO & ChairmanLeadership
Nick Howard
Global Business Unit DirectorLeadership
David Fernández
Director of Sales, EMEA & LATAMLeadership
Emma Woodmansey
Global Clinical DirectorLeadership
Sandy Fliri-Marx
Director of Human ResourcesLeadership
David Fernandez
Sales Director EMEA & LatamLeadership
Lamine Guendil
General Manager, AsiaLeadership
Adrian Parton
ChairmanBoard & advisors
Thomas Serena
AdvisorBoard & advisors
Pierre Socha
Non-Executive DirectorBoard & advisors
Michael Clancy
Non-Executive DirectorBoard & advisors
Keith Harding
AdvisorBoard & advisors
Michelle Grome
Account ManagerTeam
Tiziana Ferina
Customer Service & Logistics ManagerTeam
Lisa Foster
Sr. Clinical ManagerTeam
Stacey Martin
Project ManagerTeam
Lisa Thomas
Clinical Specialist EMEATeam
Alexander Skinner
Global Product ManagementTeam
Premium access

Complete people profiles for Natrox

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Natrox

4 dated milestones of Natrox across 21 years, from founding to its latest funding, stage changes and deals.

  1. Founded Natrox is founded.
  2. Funding First funding round of $107K.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Series C, of $33.0M.

Competitors of Natrox

Natrox operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EO2Concepts, Vaporox, Advanced Oxygen Therapy, InotecAMD and Numobag, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
eo2.com2007San Antonio, United States$31.11M19
Continuous oxygen diffusion devices for chronic wound care are developed.
vaporox.com2016Denver, United States$2.25M–
Developer of medical device for the wound treatment
aotinc.net2004Oceanside, United States––
Solutions for treating severe acute and chronic wounds are developed.
inotecamd.com2003Cambridge, United Kingdom–14
Chronic wound solutions are developed via portable oxygen-enrichment devices.
numobag.com2006Northridge, United States$950,000–
Topical hyperbaric oxygen therapy for wound healing is developed.
oz-recovery.com1995Ramat Gan, Israel––
Provides a medical device designed for chronic wound healing.
teknomar.eu1993Ankara, Turkey––
Produces sterilization devices, air sterilizers, and wound care equipment for medical use.
Premium access

Detailed competitors of Natrox

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Natrox

The website of Natrox (natroxwoundcare.com) receives about 3.7K visits a month.

  • Monthly visits
    3.7K

    ▲ 55.3% vs previous month

Latest news on Natrox

Premium access

Complete news archive for Natrox

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Natrox

10 companies that operate in the same segment as Natrox (Wound Care), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Nanotech-based wound care products are developed and provided.
2010Madison, Wisconsin, United StatesUSD 22.7 M–35
Fish-skin acellular dermal matrix technology is provided for wound treatments.
2007Isafjordur, IcelandUSD 93.11 M–150
Developer of advanced haemostat and wound care dressing products
2008Ahmedabad, Gujarat, IndiaUSD 42.71 MUSD 2.88 M70
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
1985Marietta, Georgia, United States–USD 418.63 M837
Biological drugs for skin and mucosa wound treatment are developed.
2016Uppsala, Uppsala County, SwedenUSD 4.02 MUSD 1.12 M–
Developer of hemostatic products for wound care
2010New York, New York, United StatesUSD 113.35 M––
Regenerative therapies for wound care are developed and commercialized.
1985Canton, Ohio, United StatesUSD 30 MUSD 564.17 M869
Cold plasma solutions for wound treatment are developed.
2013Eindhoven, Noord-brabant, NetherlandsUSD 7.06 M––
Point-of-care devices for wound bacterial assessment are provided.
2013Toronto, Ontario, CanadaUSD 43.2 M–49
Therapeutic solutions for biofilm prevention and removal are developed.
2001Winnipeg, Manitoba, Canada–USD 312.5 K–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Natrox

Natrox was founded in 2003 and raised its 1st funding round 2 years after it was founded.

Natrox is headquartered in Waterbeach, United Kingdom. It is registered at Waterbeach, Cambridgeshire, United Kingdom.

Gordie Nye is the current CEO of Natrox.

Natrox is a funded company, having raised a total of $68.39M across 22 funding rounds to date. The company's 1st funding round was a Seed of $311.95K, raised on Apr 2005.

Founded in 2003 and based in Waterbeach, United Kingdom, Natrox operates in the medical device sector focused on wound care. The NATROX device is developed, featuring an oxygen generator and delivery system that supplies oxygen to wounds through a single-use secondary dressing to aid healing in chronic cases. A cloud-based platform is also provided for clinical teams to capture and access patient wound care data.

Natrox's top competitors include Vaporox, Advanced Oxygen Therapy and EO2Concepts.

Natrox has 6 investors. Key investors include Amadeus Capital Partners, Meltwind Advisory, Puhua Capital, WealthClub, and Praetura Ventures.

The valuation of Natrox is $31.98M as of Nov 2019.

Natrox operates through Inotec Amd Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available